Candida albicans is the most frequent etiology of candidemia in patients with systemic autoimmune diseases.
Mortality rates among patients with systemic autoimmune diseases do not differ from those found in the general population.
To describe the epidemiological, clinical and microbiological characteristics and mortality of patients with Candida bloodstream infection and systemic autoimmune diseases.
We performed a retrospective multicenter study of candidemia in adults with systemic autoimmune diseases between 2010 and 2016.
Among 1040 patients with candidemia, 36 (3.5%) had a systemic autoimmune disease. The most common systemic autoimmune disease was rheumatoid arthritis (27.8%). The most common species was Candida albicans (66.7%). Twenty-two (61.1%) patients received a corticosteroid therapy and nine (25%) received an immunosuppressive therapy at the time of candidemia. The mortality rate was 27.8%.
Systemic autoimmune diseases are not common in patients with candidemia. The unadjusted mortality rate was comparable to other candidemia studies in the general population.Le texte complet de cet article est disponible en PDF.
Keywords : Candidemia, Corticosteroid therapy, Immunosuppressive therapy, Systemic autoimmune disease